Plexus Corp. (NASDAQ:PLXS – Get Free Report) COO Oliver Mihm sold 2,226 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $198.78, for a total transaction of $442,484.28. Following the sale, the chief operating officer owned 22,350 shares in the company, valued at approximately $4,442,733. The trade was a 9.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Plexus Price Performance
NASDAQ:PLXS traded down $0.65 during trading hours on Thursday, hitting $196.57. 249,969 shares of the stock traded hands, compared to its average volume of 362,157. The company has a market cap of $5.27 billion, a price-to-earnings ratio of 30.57 and a beta of 0.81. Plexus Corp. has a 1 year low of $103.43 and a 1 year high of $211.84. The stock has a 50 day moving average price of $174.11 and a 200 day moving average price of $152.49. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, beating the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same period last year, the firm earned $1.73 EPS. The company’s revenue was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Sell-side analysts forecast that Plexus Corp. will post 5.9 EPS for the current fiscal year.
Hedge Funds Weigh In On Plexus
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on PLXS shares. Williams Trading set a $195.00 price objective on Plexus in a research note on Wednesday, January 28th. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a report on Friday, February 6th. Sidoti downgraded Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price target for the company. in a research note on Friday, October 24th. Stifel Nicolaus increased their price objective on shares of Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a report on Friday, January 30th. Finally, Wall Street Zen cut shares of Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $189.20.
View Our Latest Stock Analysis on PLXS
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
See Also
- Five stocks we like better than Plexus
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
